nach oben

International Journal of Diabetes in Developing Countries

Erschienen in:

05.01.2018 | Review Article

Diabetes and tuberculosis in Mexico: results from epidemiological studies

verfasst von: G. Mendoza-Almanza, C. E. Rivas-Santiago, M. Salgado Bustamante, Y. López-Hernández

Erschienen in: International Journal of Diabetes in Developing Countries | Ausgabe 2/2018

Einloggen, um Zugang zu erhalten

Abstract

The association between tuberculosis (TB) and type 2 diabetes mellitus (DM2) has been recognized during centuries, and recently, a vast number of studies have evidenced their relationship. Uncontrolled diabetes and a poor glycemic control increase the risk for TB infection. Both diseases are considered chronic diseases; constituting important worldwide health problems. In Mexico, the prevalence of DM2 among TB patients varies, rising levels up to 36%. Several epidemiological studies have been conducted in the country and in the Border States, giving an estimate of the real situation of this comorbidity and in consequence, contributing to improve the diagnosis and follow-up of patients. In this review, we updated the research data on DM2 by means of observational and experimental studies conducted in Mexico in the last 17 years. Results show the continuous increase of TB-DM2 incidence and the need for the establishment of proper control methods acting over this dual axis.

Chatterjee S, Khunti K, Davies MJ. Type 2 diabetes. Lancet Lond Engl. 2017;389(10085):2239–51. https://doi.org/10.1016/S0140-6736(17)30058-2.CrossRef

Jeon CY, Murray MB. Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. PLoS Med. 2008;5(7):e152. https://doi.org/10.1371/journal.pmed.0050152.CrossRefPubMedPubMedCentral

García-Chapa EG, Leal-Ugarte E, Peralta-Leal V, Durán-González J, Meza-Espinoza JP. Genetic epidemiology of type 2 diabetes in Mexican mestizos. Biomed Res Int. 2017;2017:3937893.CrossRefPubMedPubMedCentral

Murray CJL, Ortblad KF, Guinovart C, Lim SS, Wolock TM, Roberts DA, et al. Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990-2013: a systematic analysis for the global burden of disease study 2013. Lancet Lond Engl. 2014;384(9947):1005–70. https://doi.org/10.1016/S0140-6736(14)60844-8.CrossRef

Bello-Chavolla OY, Rojas-Martinez R, Aguilar-Salinas CA, Hernández-Avila M. Epidemiology of diabetes mellitus in Mexico. Nutr Rev. 2017;75(suppl 1):4–12. https://doi.org/10.1093/nutrit/nuw030.CrossRefPubMed

Sánchez-Barriga JJ. Mortality trends and risk of dying from pulmonary tuberculosis in the 7 socioeconomic regions and the 32 states of Mexico, 2000-2009. Arch Bronconeumol. 2015;51(1):16–23. https://doi.org/10.1016/j.arbres.2014.03.020.CrossRefPubMed

Delgado-Sánchez G, García-García L, Castellanos-Joya M, Cruz-Hervert P, Ferreyra-Reyes L, Ferreira-Guerrero E, et al. Association of Pulmonary Tuberculosis and Diabetes in Mexico: analysis of the National Tuberculosis Registry 2000-2012. PLoS One. 2015;10(6):e0129312. https://doi.org/10.1371/journal.pone.0129312.CrossRefPubMedPubMedCentral

Young BN, Burgos M, Handal AJ, Baker J, Rendón A, Rosas-Taraco A, et al. Social and clinical predictors of drug-resistant tuberculosis in a public hospital, Monterrey, Mexico. Ann Epidemiol. 2014;24(10):771–5. https://doi.org/10.1016/j.annepidem.2014.07.001.CrossRefPubMed

Kumar Nathella P, Babu S. Influence of diabetes mellitus on immunity to human tuberculosis. Immunology. 2017;152(1):13–24. https://doi.org/10.1111/imm.12762.CrossRefPubMed

10.

Saiki O, Negoro S, Tsuyuguchi I, Yamamura Y. Depressed immunological defence mechanisms in mice with experimentally induced diabetes. Infect Immun. 1980;28(1):127–31.PubMedPubMedCentral

11.

Sugawara I, Mizuno S. Higher susceptibility of type 1 diabetic rats to mycobacterium tuberculosis infection. Tohoku J Exp Med. 2008;216(4):363–70. https://doi.org/10.1620/tjem.216.363.CrossRefPubMed

12.

Podell BK, Ackart DF, Obregon-Henao A, Eck SP, Henao-Tamayo M, Richardson M, et al. Increased severity of tuberculosis in Guinea pigs with type 2 diabetes: a model of diabetes-tuberculosis comorbidity. Am J Pathol. 2014;184(4):1104–18. https://doi.org/10.1016/j.ajpath.2013.12.015.CrossRefPubMedPubMedCentral

13.

Arce-Mendoza A, Rodriguez-de Ita J, Salinas-Carmona MC, Rosas-Taraco AG. Expression of CD64, CD206, and RAGE in adherent cells of diabetic patients infected with mycobacterium tuberculosis. Arch Med Res. 2008;39(3):306–11. https://doi.org/10.1016/j.arcmed.2007.11.013.CrossRefPubMed

14.

Lopez-Lopez N, Gonzalez-Curiel I, Castañeda-Delgado J, Montoya-Rosales A, Gandara-Jasso B, Enciso-Moreno JA, et al. Vitamin D supplementation promotes macrophages’ anti-mycobacterial activity in type 2 diabetes mellitus patients with low vitamin D receptor expression. Microbes Infect. 2014;16(9):755–61. https://doi.org/10.1016/j.micinf.2014.06.010.CrossRefPubMed

15.

Montoya-Rosales A, Castro-Garcia P, Torres-Juarez F, Enciso-Moreno JA, Rivas-Santiago B. Glucose levels affect LL-37 expression in monocyte-derived macrophages altering the mycobacterium tuberculosis intracellular growth control. Microb Pathog. 2016;97:148–53. https://doi.org/10.1016/j.micpath.2016.06.002.CrossRefPubMed

16.

ZHAN Y, JIANG L. Status of vitamin D, antimicrobial peptide cathelicidin and T helper-associated cytokines in patients with diabetes mellitus and pulmonary tuberculosis. Exp Ther Med. 2015;9(1):11–6. https://doi.org/10.3892/etm.2014.2042.CrossRefPubMed

17.

Restrepo BI, Fisher-Hoch SP, Pino PA, Salinas A, Rahbar MH, Mora F, et al. Tuberculosis in poorly controlled type 2 diabetes: altered cytokine expression in peripheral white blood cells. Clin Infect Dis Off Publ Infect Dis Soc Am. 2008;47(5):634–41. https://doi.org/10.1086/590565.CrossRef

18.

Perez-Guzman C, Torres-Cruz A, Villarreal-Velarde H, Vargas MH. Progressive age-related changes in pulmonary tuberculosis images and the effect of diabetes. Am J Respir Crit Care Med. 2000;162(5):1738–40. https://doi.org/10.1164/ajrccm.162.5.2001040.CrossRefPubMed

19.

Pérez A, Brown HS, Restrepo BI. Association between tuberculosis and diabetes in the mexican border and non-border regions of Texas. Am J Trop Med Hyg. 2006;74(4):604–611.

20.

Restrepo BI, Fisher-Hoch SP, Crespo JG, Whitney E, Perez A, Smith B, et al. Type 2 diabetes and tuberculosis in a dynamic bi-national border population. Epidemiol Infect. 2007;135(03):483–91. https://doi.org/10.1017/S0950268806006935.CrossRefPubMed

21.

Abdelbary BE, Garcia-Viveros M, Ramirez-Oropesa H, Rahbar MH, Restrepo BI. Tuberculosis-diabetes epidemiology in the border and non-border regions of Tamaulipas. Mex Tuberc Edinb Scotl. 2016;101S:S124–34.

22.

Chittoor G, Arya R, Farook VS, David R, Puppala S, Resendez RG, et al. Epidemiologic investigation of tuberculosis in a Mexican population from Chihuahua State, Mexico: a pilot study. Tuberc Edinb Scotl. 2013;93(Suppl):S71–7.CrossRef

23.

Gómez-Gómez A, Magaña-Aquino M, López-Meza S, Aranda-Álvarez M, Díaz-Ornelas DE, Hernández-Segura MG, et al. Diabetes and other risk factors for multi-drug resistant tuberculosis in a Mexican population with pulmonary tuberculosis: case control study. Arch Med Res. 2015;46(2):142–8. https://doi.org/10.1016/j.arcmed.2015.01.006.CrossRefPubMed

24.

Fisher-Hoch SP, Whitney E, McCormick JB, Crespo G, Smith B, Rahbar MH, et al. Type 2 diabetes and multidrug-resistant tuberculosis. Scand J Infect Dis. 2008;40(11-12):888–93. https://doi.org/10.1080/00365540802342372.CrossRefPubMedPubMedCentral

25.

Pérez-Navarro LM, Fuentes-Domínguez F, Morales-Romero J, Zenteno-Cuevas R. Factors associated to pulmonary tuberculosis in patients with diabetes mellitus from Veracruz, México. Gac Med Mex. 2011;147(3):219–25.PubMed

26.

Pérez-Navarro LM, Fuentes-Domínguez FJ, Zenteno-Cuevas R. Type 2 diabetes mellitus and its influence in the development of multidrug resistance tuberculosis in patients from southeastern Mexico. J Diabetes Complicat. 2015;29(1):77–82. https://doi.org/10.1016/j.jdiacomp.2014.09.007.CrossRefPubMed

27.

Young BN, Rendón A, Rosas-Taraco A, Baker J, Healy M, Gross JM, et al. The effects of socioeconomic status, clinical factors, and genetic ancestry on pulmonary tuberculosis disease in northeastern Mexico. PLoS One. 2014;9(4):e94303. https://doi.org/10.1371/journal.pone.0094303.CrossRefPubMedPubMedCentral

28.

Gonzalez-Curiel I, Castañeda-Delgado J, Lopez-Lopez N, Araujo Z, Hernandez-Pando R, Gandara-Jasso B, et al. Differential expression of antimicrobial peptides in active and latent tuberculosis and its relationship with diabetes mellitus. Hum Immunol. 2011;72(8):656–62. https://doi.org/10.1016/j.humimm.2011.03.027.CrossRefPubMed

29.

Montoya-Rosales A, Provvedi R, Torres-Juarez F, Enciso-Moreno JA, Hernandez-Pando R, Manganelli R, et al. lysX gene is differentially expressed among Mycobacterium tuberculosis strains with different levels of virulence. Tuberc Edinb Scotl. 2017;106:106–17.CrossRef

30.

Hernández-Guerrero IA, Vázquez-Martínez VH, Guzmán-López F, Ochoa-Jiménez LG, Cervantes-Vázquez DA. Perfil clínico y social de pacientes con tuberculosis en una unidad de medicina familiar de Reynosa, Tamaulipas. Méx Aten Fam. 2016;23(1):8–13. https://doi.org/10.1016/S1405-8871(16)30070-0.CrossRef

31.

Restrepo BI, Camerlin AJ, Rahbar MH, Wang W, Restrepo MA, Zarate I, et al. Cross-sectional assessment reveals high diabetes prevalence among newly-diagnosed tuberculosis cases. Bull World Health Organ. 2011;89(5):352–9. https://doi.org/10.2471/BLT.10.085738.CrossRefPubMedPubMedCentral

32.

Stew SS, Martinez PJ, Schlesinger LS, Restrepo BI. Differential expression of monocyte surface markers among TB patients with diabetes co-morbidity. Tuberc Edinb Scotl. 2013;93:S78–82. https://doi.org/10.1016/S1472-9792(13)70015-5.CrossRef

33.

Martínez-Aguilar G, Serrano CJ, Castañeda-Delgado JE, Macías-Segura N, Hernández-Delgadillo N, Enciso-Moreno L, et al. Associated risk factors for latent tuberculosis infection in subjects with diabetes. Arch Med Res. 2015;46(3):221–7. https://doi.org/10.1016/j.arcmed.2015.03.009.CrossRefPubMed

34.

Oren E, Fiero MH, Barrett E, Anderson B, Nuῆez M, Gonzalez-Salazar F. Detection of latent tuberculosis infection among migrant farmworkers along the US-Mexico border. BMC Infect Dis. 2016;16(1):630. https://doi.org/10.1186/s12879-016-1959-3.CrossRefPubMedPubMedCentral

35.

Ponce-De-Leon A. Garcia-Garcia Md M de L, Garcia-Sancho MC, Gomez-Perez FJ, Valdespino-Gomez JL, Olaiz-Fernandez G, et al. Tuberculosis and diabetes in southern Mexico. Diabetes Care. 2004;27(7):1584–90. https://doi.org/10.2337/diacare.27.7.1584.CrossRefPubMed

36.

Jiménez-Corona ME, Cruz-Hervert LP, García-García L, Ferreyra-Reyes L, Delgado-Sánchez G. Bobadilla-del-Valle M, et al. association of diabetes and tuberculosis: impact on treatment and post-treatment outcomes. Thorax. 2013;68(3):214–20. https://doi.org/10.1136/thoraxjnl-2012-201756.CrossRefPubMed

37.

Perez-Navarro LM, Restrepo BI, Fuentes-Dominguez FJ, Duggirala R, Morales-Romero J, López-Alvarenga JC, et al. The effect size of type 2 diabetes mellitus on tuberculosis drug resistance and adverse treatment outcomes. Tuberc Edinb Scotl. 2017;103:83–91. https://doi.org/10.1016/j.tube.2017.01.006.CrossRef

38.

Medellín-Garibay SE, Cortez-Espinosa N, Milán-Segovia RC, Magaña-Aquino M, Vargas-Morales JM, González-Amaro R, et al. Clinical pharmacokinetics of rifampin in patients with tuberculosis and type 2 diabetes mellitus: association with biochemical and immunological parameters. Antimicrob Agents Chemother. 2015;59(12):7707–14. https://doi.org/10.1128/AAC.01067-15.CrossRefPubMedPubMedCentral

39.

Muñoz-Torrico M, Caminero-Luna J, Migliori GB, D’Ambrosio L, Carrillo-Alduenda JL, Villareal-Velarde H, et al. Diabetes is associated with severe adverse events in multidrug-resistant tuberculosis. Arch Bronconeumol. 2017;53(5):245–50. https://doi.org/10.1016/j.arbres.2016.10.021.CrossRefPubMed

40.

Castellanos-Joya M, Delgado-Sánchez G, Ferreyra-Reyes L, Cruz-Hervert P, Ferreira-Guerrero E, Ortiz-Solís G, et al. Results of the implementation of a pilot model for the bidirectional screening and joint management of patients with pulmonary tuberculosis and diabetes mellitus in Mexico. PLoS One. 2014;9(9):e106961. https://doi.org/10.1371/journal.pone.0106961.CrossRefPubMedPubMedCentral

41.

Viswanathan V, Kumpatla S, Aravindalochanan V, Rajan R, Chinnasamy C, Srinivasan R, et al. Prevalence of diabetes and pre-diabetes and associated risk factors among tuberculosis patients in India. PLoS One. 2012;7(7):e41367. https://doi.org/10.1371/journal.pone.0041367.CrossRefPubMedPubMedCentral

42.

Kornfeld H, West K, Kane K, Kumpatla S, Zacharias RR, Martinez-Balzano C, et al. High prevalence and heterogeneity of diabetes in patients with TB in South India: a report from the effects of diabetes on tuberculosis severity (EDOTS) study. Chest. 2016;149(6):1501–8. https://doi.org/10.1016/j.chest.2016.02.675. CrossRefPubMedPubMedCentral

43.

Balakrishnan S, Vijayan S, Nair S, Subramoniapillai J, Mrithyunjayan S, Wilson N, et al. High diabetes prevalence among tuberculosis cases in Kerala, India. PLoS One. 2012;7(10):e46502. https://doi.org/10.1371/journal.pone.0046502.CrossRefPubMedPubMedCentral

44.

Singla R, Khan N, Al-Sharif N, Ai-Sayegh MO, Shaikh MA, Osman MM. Influence of diabetes on manifestations and treatment outcome of pulmonary TB patients. Int J Tuberc Lung Dis. 2006 Jan;10(1):74–9.PubMed

45.

Wang PD, Lin RS. Epidemiologic features of diabetics among tuberculosis patients in Taiwan. J Infect Dis Antimicrob Agents. 2000;17:101–5.

Titel: Diabetes and tuberculosis in Mexico: results from epidemiological studies
verfasst von: G. Mendoza-Almanza
C. E. Rivas-Santiago
M. Salgado Bustamante
Y. López-Hernández
Publikationsdatum: 05.01.2018
Verlag: Springer India
Erschienen in: International Journal of Diabetes in Developing Countries / Ausgabe 2/2018
Print ISSN: 0973-3930
Elektronische ISSN: 1998-3832
DOI: https://doi.org/10.1007/s13410-017-0599-5

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Diabetes and tuberculosis in Mexico: results from epidemiological studies

Abstract

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2018

Evaluating prescription adherence to evidence-based guidelines in diabetes management: a reply to Pingili et al. (2017)

Effect of vitamin D supplementation on reduction of cardiometabolic risk in patients with type 2 diabetes mellitus and dyslipidemia

Severe hypoglycemia in diabetics requiring hospitalization and short-term mortality

Preventing and managing diabetic foot ulcers: application of Orem’s self-care model

Prevalence of diabetes and co-morbidities in five rural and semi-urban Kenyan counties, 2010–2015

The protective effect of the Pro12Ala polymorphism of peroxisome proliferator-activated receptor γ (PPARγ) isoform 2 in progression to diabetes in a Pakistani cohort